Perspecta Releases New Industry Research on Provider Data Quality & Directory Inaccuracies Across U.S. Health Plans

Perspecta released The State of Provider Data Accuracy, based on 12 months of provider directory audits covering millions of provider records, finding average provider data accuracy around 50% and only 31% of members trusting their health plan’s ability to find the right provider. The report attributes most directory errors to five high-risk fields (address, location name, phone, fax, specialty) and argues periodic attestation/manual outreach is insufficient as provider information changes continuously. It highlights operational downstream impacts across regulatory exposure, claims processing, credentialing, network adequacy monitoring, and member experience, recommending continuous systematic auditing and data governance to reduce error rates.

Analysis

This is less a one-off data quality story than a reminder that provider directories are now a P&L line item. The economic winner is whoever can turn continuous cleanup into a recurring workflow: that favors healthcare BPO/data ops vendors and payer platforms with claims-linked source-of-truth systems, while smaller plans and delegated networks with fragmented admin stacks absorb the highest compliance and call-center drag. The second-order effect is not just penalty avoidance; bad data leaks members into the wrong channels, inflates avoidable utilization friction, and quietly raises SG&A through manual remediation.

The market consequence should be slow-burn, not same-day. Over the next 1-3 months, expect procurement chatter and RFP language to shift toward continuous auditing, which could create a modest tailwind for outsourced operations vendors; over 6-18 months, the more durable benefit accrues to incumbents that can prove lower complaint rates and better network adequacy scores. The vulnerable names are regional and ACA-heavy payers where directory quality can translate into higher churn, worse service metrics, and more regulator attention. If a plan can show materially lower member abrasion, that becomes a moat; if not, the issue compounds because the remediation burden is continuous, not episodic.

The contrarian miss is that investors may treat this as a compliance housekeeping issue when it is actually a retention and distribution problem. If member trust is weak, the real cost is reduced plan stickiness and higher acquisition expense, which is harder to quantify than fines but more persistent. The thesis fails if payers can demonstrate that claims, CRM, and provider-credentialing data are already integrated enough to drive rapid auto-correction; otherwise, the problem should keep surfacing in earnings calls as a slow margin bleed rather than a headline risk.

Key Decisions for Investors

• Watchlist: initiate a conditional long in EXLS on any pullback if payer RFPs/earnings commentary confirm outsourcing of provider-data remediation; time horizon 3-6 months, with upside from recurring admin work and limited direct balance-sheet risk.
• Relative-value idea: long EXLS / short a basket of administratively heavy payers (UNH, CVS, CNC) only if next-quarter commentary shows rising SG&A or member complaint metrics tied to directory maintenance; this is a hedge against compliance drag, not a directional bet on healthcare demand.
• Do not force a trade in the managed care group immediately; wait for corroboration in earnings season on complaint trends, network adequacy, or admin-cost guidance. If no follow-through appears, the market is likely to fade the story within days.
• Set an alert on MOH and CNC around next guidance revisions: any mention of elevated manual remediation, call-center load, or quality-metric pressure would be a catalyst to short on rallies, with a 1-3 month horizon.
• If a public healthcare IT/data-vendor proxy (e.g., PATH for workflow automation) gets bid on 'AI in operations' enthusiasm, fade it unless management can show healthcare-specific conversion; the catalyst here is workflow integration, not generic automation hype.